Advisors Asset Management »

Catalyst Pharmaceutical Partners shares owned by Advisors Asset Management

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Advisors Asset Management from 13F filings

Historical chart of Advisors Asset Management investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Advisors Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Advisors Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.4M 201k 16.81
2023-09-30 $3.7M 319k 11.69
2023-06-30 $4.3M 322k 13.44
2023-03-31 $5.3M 319k 16.58
2022-12-31 $5.9M 318k 18.60
2022-09-30 $3.2M 251k 12.83
2022-06-30 $1.7M 249k 7.01
2022-03-31 $1.1M 135k 8.29
2021-12-31 $298k 44k 6.78

More positions owned by Advisors Asset Management

Amazon (AMZN)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Visa Com Cl A (V)
Verizon Communications (VZ)
Mastercard Incorporated Cl A (MA)
International Business Machines (IBM)
Eli Lilly & Co. (LLY)
Abbvie (ABBV)
3M Company (MMM)
Chevron Corporation (CVX)
Merck & Co (MRK)

View all positions for Advisors Asset Management

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Henderson Group
Geode Capital Management
Royce & Associates
Morgan Stanley
Marshall Wace
Robeco Investment Management
Northern Trust
Jacobs Levy Equity Management
T. Rowe Price Associates
Citadel Advisors
Voloridge Investment Management

View all funds holding Catalyst Pharmaceutical Partners